Obesity Clinical Trial
Official title:
Primary Prevention of Rapid Weight Gain in Early Childhood: a Randomised Controlled Trial
Obesity is one of the biggest threats to health in the 21st century. Rapid weight gain in the
first year of life tends to lead to overweight in children, which in turn leads to overweight
in adults. This rapid early weight gain occurs most often at weaning when eating patterns
emerge. Infant sleep problems also appear to be associated with the risk of becoming
overweight, and contribute to maternal post-natal depression. We propose to undertake a 4-arm
randomised controlled trial to determine whether extra education and support for families
around weaning and development of early food and activity habits, with or without
intervention to improve infant sleep, will decrease the current risk patterns of rapid
excessive early childhood weight gain in New Zealand. This would provide strong evidence for
the value of such a strategy in the long term control of the obesity epidemic and its
consequent complications.
This is a two-year intervention with follow-ups at 3.5, 5 and 11 years of age.
We plan on undertaking a 4-arm randomised controlled trial to test the following hypotheses:
1. That anticipatory guidance and extra education and support in infancy around weaning and
decreasing/avoiding television watching will delay the timing of introduction of solid
foods, will be associated with more successful introduction of nutrient dense foods with
appropriate portion size and decrease small screen exposure leading to a lower number of
children with excessive weight velocity in infancy and early childhood.
2. That anticipatory guidance, education and extra support around the early development of
infant sleeping patterns will decrease sleep problems, increase infant sleeping time,
decrease arousals at night and lower sleep latency which will in turn influence rate of
early infant weight gain.
3. That interventions 1 and 2 will interact additively with regard to infant and early
childhood weight gain.
4. That intervention 2 will lead to lower rates of maternal depression and increased family
well being.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |